0000950172-16-000147.txt : 20160126 0000950172-16-000147.hdr.sgml : 20160126 20160126134903 ACCESSION NUMBER: 0000950172-16-000147 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160126 DATE AS OF CHANGE: 20160126 EFFECTIVENESS DATE: 20160126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aequus Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001664767 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-255970 FILM NUMBER: 161360895 BUSINESS ADDRESS: STREET 1: 2820-200 GRANVILLE STREET CITY: VANCOUVER STATE: A1 ZIP: BC V6C 1S4 BUSINESS PHONE: (604) 336-7906 MAIL ADDRESS: STREET 1: 2820-200 GRANVILLE STREET CITY: VANCOUVER STATE: A1 ZIP: BC V6C 1S4 D 1 primary_doc.xml X0707 D LIVE 0001664767 Aequus Pharmaceuticals Inc. 2820-200 GRANVILLE STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 (604) 336-7906 BRITISH COLUMBIA, CANADA None None Corporation true 2013 Doug Janzen 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Executive Officer Director Anne Stevens 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Executive Officer Director Christina Yip 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Executive Officer ian Ball 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Executive Officer Donald McAfee 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Executive Officer Fotios Plakogiannis 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Director Chris Clark 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Director Jason Flowerday 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Director Rodoula Plakogiannis 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Director Hamed Shahbazi 2820-200 Granville Street Vancouver A1 BRITISH COLUMBIA, CANADA BC V6C 1S4 Director Biotechnology No Revenues 06b false 2016-01-12 false true false 0 628828 628828 0 C$1.00 = US$0.6997 (Bank of Canada noon exchange rate 1/12/16). C$898,711 sold in United States pursuant to Rule 506(b) of Regulation D. Issuer conducted concurrent public offering in Canada for C$1,750,000 pursuant to Regulation S. false 7 0 0 0 false Aequus Pharmaceuticals Inc. /s/ Christina Yip Christina Yip Chief Financial Officer 2016-01-26